Pfizer Acquires ADC Developer Seagen in $43B Deal
Pfizer is beefing up its oncology portfolio by acquiring ADC pioneer Seagen for a total deal value of $43 billion.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
